Realising the Broader Value of Vaccines in the UK

Simon Brassel;Margherita Neri;Phill O’Neill;Lotte Steuten

Contract Research from Office of Health Economics

Abstract: Many health technology assessment (HTA) agencies limit their assessment of vaccines to individual health benefits and the costs associated with vaccine administration and the disease avoided. However, compared to other health technologies, the standard evaluation approaches have often been criticised as inadequate to accurately estimate the value of vaccines. This study uses a newly designed framework to capture the broader value of 10 selected vaccines with a high likelihood of entering the UK within the next decade. The findings qualify the critical gaps between value generation through vaccination and value recognition by relevant regulators. Recommendations are given to prevent the systematic undervaluation of future vaccines.

Keywords: Realising; the; Broader; Value; of; Vaccines; in; the; UK (search for similar items in EconPapers)
JEL-codes: I1 (search for similar items in EconPapers)
Date: 2020-08-01
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.ohe.org/publications/realising-broader ... ines-report_1_final/ (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ohe:conres:002282

Access Statistics for this paper

More papers in Contract Research from Office of Health Economics Contact information at EDIRC.
Bibliographic data for series maintained by Publications Manager ( this e-mail address is bad, please contact ).